SCHEMBL3217229

SCHEMBL3217229

BrC1C[CH]C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4387613 0.79
SCHEMBL11843126 0.76
SCHEMBL193236 0.68
SCHEMBL6571695 0.65
SCHEMBL456607 0.63
SCHEMBL13719072 0.63
SCHEMBL385186 0.61
SCHEMBL289020 0.60
SCHEMBL1766118 0.60
SCHEMBL5596487 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399209-A1 NEW QUINOLINE DERIVATIVES Elanco Animal Health GmbH (DE) 2024-07-17 EP claimed
CN-117957223-A Quinoline derivatives 礼蓝动物保健有限公司 2024-04-30 CN claimed
WO-2023036821-A1 NEW QUINOLINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2023-03-16 WO claimed
EP-4148052-A1 NEW QUINOLINE DERIVATIVES Bayer Animal Health GmbH (DE) 2023-03-15 EP claimed
EP-4399209-A1 NEW QUINOLINE DERIVATIVES Elanco Animal Health GmbH (DE) 2024-07-17 EP disclosed
CN-117957223-A Quinoline derivatives 礼蓝动物保健有限公司 2024-04-30 CN disclosed
CN-115956070-A Sulfonamide compounds 阿纳克西斯制药股份有限公司 2023-04-11 CN disclosed
WO-2023036821-A1 NEW QUINOLINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2023-03-16 WO disclosed
EP-4148052-A1 NEW QUINOLINE DERIVATIVES Bayer Animal Health GmbH (DE) 2023-03-15 EP disclosed
EP-3636651-A1 HEXAHYDROPYRAZINOBENZ- OR -PYRIDO-OXAZEPINES CARRYING AN OXYGEN-CONTAINING SUBSTITUENT AND USE THEREOF IN THE TREATMENT OF 5-HT2C-DEPENDENT DISORDERS AbbVie Deutschland GmbH & Co. KG (DE) 2020-04-15 EP disclosed
US-20190135777-A1 QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR AbbVie Deutschland GmbH & Co. KG (DE) 2019-05-09 US disclosed
US-10160744-B2 Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor AbbVie Deutschland GmbH & Co. KG (DE) 2018-12-25 US disclosed
CN-101578278-A Substituted 1- (azolin-2-yl) -amino-1, 2-heterocyclyl-ethane compounds for combating pests BASF SE (DE) 2009-11-11 CN disclosed
EP-2061781-A1 SUBSTITUTED 1-(AZOLIN-2-YL)-AMINO-1,2-HETEROCYCLYL-ETHANE COMPOUNDS FOR COMBATING PESTS BASF SE (DE) 2009-05-27 EP disclosed
WO-2008074686-A1 SUBSTITUTED 1-(AZOLIN-2-YL)-AMINO-1,2-HETEROCYCLYL-ETHANE COMPOUNDS FOR COMBATING PESTS BASF SE (DE) 2008-06-26 WO disclosed
CN-1960993-A 6, 6-bicyclic substituted heterobicyclic protein kinase inhibitors OSI PHARM INC (US) 2007-05-09 CN disclosed
CN-1449378-A Benzoyl cyclohexanediones with herbicidal activity AVENTIS CROPSCIENCE GMBH (DE) 2003-10-15 CN disclosed
EP-0042107-B1 DIHYDROPYRIDAZINONES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BASF Aktiengesellschaft (DE) 1985-04-03 EP disclosed
US-4410529-A HYPOTENSIVE AGNENTS, ANTICOAGULANTS BASF AKTIENGESELLSCHAFT (DE) 1983-10-18 US disclosed
EP-0042107-A1 Dihydropyridazinones, processes for their preparation and pharmaceutical compositions containing these compounds BASF Aktiengesellschaft (DE) 1981-12-23 EP disclosed